Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. In expanding its drug development efforts in the field of cancer through its proprietary targeted cancer programs, Curis is building upon its previous experiences in targeting signaling pathways for the development of next generation targeted cancer therapies.
Lexington, US
Size (employees)
44 (est)
Curis was founded in 2000 and is headquartered in Lexington, US

Curis Office Locations

Curis has an office in Lexington
Lexington, US (HQ)
4 Maguire Rd

Curis Data and Metrics

Curis Financial Metrics

Curis's revenue was reported to be $7.5 m in 2016
$, USD

Revenue (Y, 2016)

7.5 m

Revenue growth (Y, 2015 - Y, 2016), %


Net income (Y, 2016)

(60.4 m)

EBIT (Y, 2016)

(58 m)

Market capitalization (23-Jun-2017)

301.9 m

Closing share price (23-Jun-2017)


Cash (31-Dec-2016)

26 m
Curis's current market capitalization is $301.9 m.
$, USDFY, 2013FY, 2014FY, 2015Y, 2016


15 m9.8 m7.9 m7.5 m

Revenue growth, %


Operating expense total

24.4 m25.7 m64.4 m65.6 m


(9.4 m)(15.9 m)(56.5 m)(58 m)

EBIT margin, %


Interest expense

3.8 m3.7 m3.3 m2.8 m

Interest income

164.7 k165.1 k277.3 k406 k

Net Income

(12.3 m)(18.7 m)(59 m)(60.4 m)
$, USDFY, 2013FY, 2014FY, 2015FY, 2016


9.6 m7.7 m33.1 m26 m

Accounts Receivable

1.5 m2 m2.1 m2.5 m


495.3 k489.8 k1.2 m1.3 m

Current Assets

60.2 m52.2 m85.5 m48.2 m


445.7 k407.7 k277.7 k413 k


9 m9 m9 m9 m

Total Assets

80.6 m62.6 m95 m57.8 m

Accounts Payable

2 m2.3 m4.2 m5.9 m

Current Liabilities

6.6 m10.1 m10.8 m13.5 m

Additional Paid-in Capital

806.7 m810 m903.2 m928.3 m

Retained Earnings

(760.8 m)(779.6 m)(838.5 m)(898.9 m)

Total Equity

45.2 m29.8 m64.5 m29.3 m

Financial Leverage

1.8 x2.1 x1.5 x2 x
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(12.3 m)(18.7 m)(59 m)(60.4 m)

Depreciation and Amortization

141.5 k155.1 k160.8 k193 k

Accounts Receivable

(569.1 k)(483.8 k)(145 k)(353 k)

Cash From Operating Activities

(9.5 m)(16.8 m)(29.9 m)(35.8 m)

Cash From Investing Activities

(13.6 m)16.3 m(6.4 m)30.1 m

Cash From Financing Activities

20 m(1.3 m)61.7 m(1.4 m)

Interest Paid

2.9 m4.4 m3.3 m2.8 m
$, USDY, 2016


171.1 k

Financial Leverage

2 x

Curis Market Value History

Curis Company Life and Culture

You may also be interested in